Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004
Practice Parameter: Pharmacological Treatment of Migraine Headache in Children and Adolescents
Neurol 63:2215-2224, Lewis,D.,et al, 2004
Migraine and Other Headaches
Neurol 63:2233-2239,2209, Rose,K.M.,et al, 2004
Recurrent Longitudinal Myelitis as Primary Manifestation of SLE
Neurol 63:1976, Lehnhardt,F.-G.,et al, 2004
Early Epidural Blood Patch in Spontaneous Intracranial Hypotension
Neurol 63:1950-1951, Berroir,S.,et al, 2004
Epileptic Seizures in Systemic Lupus Erythematosus
Neurol 63:1808-1812, Appenzeller,S.,et al, 2004
Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage
Stroke 35:1415-1420, Greenberg,S.M.,et al, 2004
Aortic Arch Atherosclerotic Lesions and the Recurrence of Ischemic Stroke
Stroke 35:1426-1429, Fujimoto,S.,et al, 2004
A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine
Neurol 63:261-269,202, Silberstein,S.D.,et al, 2004
Self-Treatment of Benign Paroxysmal Positional Vertigo
Neurol 63:150-152,8, Radtke,A.,et al, 2004
Fever, Headache, and a Stiff Neck
Lancet 363:1868, Ma,R.C.W.,et al, 2004
Seizure Outcomes After Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations
Neurol 63:683-687, Schauble,B.,et al, 2004
Efficacy of Mycophenolate Mofetil in Patients with Chronic Immune Demyelinating Polyneuropathy
NEruol 63:715-717, Gorson,K.C.,et al, 2004
Melatonin, 3 mg, is Effective for Migraine Prevention
Neurol 63:757, Peres,M.F.P.,et al, 2004
Poststroke Neurological Improvement Within 7 Days Is Associated with Subsequent Deterioration
Stroke 35:2165, Aslanyan,S.,et al, 2004
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Does Transcatheter Closure of Patent Foramen Ovale Really "Shut the Door?"
Stroek 35:2140, Anzola,G.P.,et al, 2004
Migraine Is Associated With Magnetic Resonance Imaging White Matter Abnormalities
Arch Neurol 61:1366-1368, Swartz,R.H.,et al, 2004
The Natural History of Recurrent Optic Neuritis
Arch Neurol 61:1401-1405, Pirko,I.,et al, 2004
Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis
NEJM 351:1849-1859,1826, van de Beek,D.,et al, 2004
Progressive Posterior Cortical Dysfunction
Neurol 63:1175-1180, Renner,J.A.,et al, 2004
PROTECT A Coordinated Stroke Treatment Program to Prevent Recurrent Thromboembolic Events
Neurol 63:1217-1222, Ovbiagele,B.,et al, 2004
Multiple Acute Cerebral Infarcts on Diffusion-Weighted Imaging and Risk of Recurrent Stroke
Neurol 63:1317-1319, Wen,H.M.,et al, 2004
Recurrent Lymphocytic Meningitis
Arch Neurol 61:1553-1557, Kupila,L.,et al, 2004
White Matter Lesions, Congition, and Recurrent Hemorrhage in Lobar Intracerebral Hemorrhage
Neurol 63:1606-1612, Smith,E.E.,et al, 2004
Idiopathic Intracranial Hypertension
Neurol 63:1737-1739, Kesler,A.,et al, 2004
Clinical Spectrum of Episodic Ataxia Type 2
Neurol 62:17-22, Jen,J.,et al, 2004
Recurrent Transverse Myelitis Associates with Anti-Ro (SSA) Autoantibodies
Neurol 62:147-149, Hummers,L.K.,et al, 2004
Migraine
Lancet 363:381-391, Silberstein,S.D., 2004
Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
JAMA 291:565-575,621, Toole,J.F.,et al, 2004
Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients with Ischemic Stroke
JAMA 291:576-584, The APASS Investigators, 2004
Migraine as a Risk Factor for Subclinical Brain Lesions
JAMA 291:427-434, Kruit,M.C.,et al, 2004
Babesiosis and HIV
Lancet 363:704, Froberg,M.K.,et al, 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Trpitans in Migraine
Neurol 62:563-568, Hall,G.C.,et al, 2004
Early Risk of Recurrence by Subtype of Ischemic Stroke in Population-Based Incidence Studies
Neurol 62:569-573, Lovett,J.K.,et al, 2004
Initial Misdiagnosis and Outcome After Subarachnoid Hemorrhage
JAMA 291:866-869, Kowalski,R.G.,et al, 2004
Idiopathic Hypertrophic Pachymeningitis
Neurol 62:686-694, Kupersmith,M.J.,et al, 2004
Acute Facial Diplegia and Hyperreflexia
Neurol 62:825-827, Susuki,K.,et al, 2004
Response of Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL) to Topotecan
Neurol 62:1885-1887, Fischer,L.,et al, 2004
Migraine Practice Patterns Among Neurologists
Neurol 62:1926-1931, Lipton,R.B.,et al, 2004
Topiramate in Migraine Prevention
Arch Neurol 61:490-495, Silberstein,S.D.,et al, 2004
Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm
Neurol 62:1042-1050, Messe,S.R.,et al, 2004
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Use of Narcotic Analgesics in the Emergency Department Treatment of Migraine Headache
Neurol 62:1695-1700,1662, Colman,I.,et al, 2004
Nimodipine for Treatment of Primary Thunderclap Headache
Neurol 62:1414-1416, Lu,S.-R.,et al, 2004
Brainstem Involvement in Hypertensive Encephalopathy
Neurol 62:1417-1419, Cruz-Flores,S.,et al, 2004
Closure of a Patent Foramen Ovale is Associated with a Decrease in Prevalence of Migraine
Neurol 62:1439-1440, Post,M.C.,et al, 2004
Fibromuscular Dysplasia
NEJM 350:1862-1871, Slovut,D.P. &Olin,J.W., 2004